A patient arrives in the emergency department with sudden shortness of breath, bilateral crackles, and rapidly falling oxygen saturation. Acute pulmonary edema is suspected, but management depends directly on the underlying mechanism. Cardiogenic, non-cardiogenic, or volume-overload pulmonary edema: each type follows a distinct pathophysiological process, and misclassifying it can lead to inappropriate treatment.
Knowing the three main types of pulmonary edema and their characteristics makes it possible to tailor treatment from the very first minutes. Here, we explain what sets them apart in practice, from bedside assessment to imaging.
Pulmonary capillary pressure: the criterion that distinguishes cardiogenic from non-cardiogenic pulmonary edema
When classifying pulmonary edema, the first question concerns the alveolar-capillary membrane. Is it intact or damaged? The answer divides the three types into two broad groups.
In cardiogenic pulmonary edema, the membrane remains intact. The problem is an increase in hydrostatic pressure in the pulmonary capillaries, most often due to left ventricular failure. Blood backs up, pressure rises, and plasma fluid is forced through the capillary wall into the alveoli. The resulting fluid is a protein-poor transudate.
In non-cardiogenic pulmonary edema, capillary pressure may be normal. The endothelial barrier itself is damaged (by infection, toxic inhalation, or sepsis), allowing a protein-rich exudate containing inflammatory cells to leak into the alveolar space. Imaging shows bilateral opacities in both cases, making it difficult to distinguish them on a chest X-ray alone.
This point is often underestimated in practice. According to the 2024 global definition of ARDS (Matthay et al., American Journal of Respiratory and Critical Care Medicine), bilateral lung opacities alone are not enough to distinguish cardiogenic from non-cardiogenic pulmonary edema. Cardiac assessment is still necessary before deciding on treatment.
Cardiogenic pulmonary edema: left-sided heart failure and acute decompensation
This is the most common type. It occurs in patients with known left-sided heart failure, but can also arise de novo, without any identified history of heart disease. The left ventricle can no longer pump blood effectively into the aorta, causing pulmonary congestion upstream.
Clinical signs and rapid diagnosis
The presentation is often dramatic: severe shortness of breath, orthopnea, pink frothy sputum, and bilateral crackles on auscultation. Blood pressure is a useful immediate indicator. Hypertension at the time of pulmonary edema points to a hypertensive crisis as a trigger, while low blood pressure suggests cardiogenic shock and a poorer prognosis.
Echocardiography can identify structural abnormalities of the heart (valvular disease, systolic or diastolic dysfunction) and confirm a cardiac cause. Measuring natriuretic peptides (BNP or NT-proBNP) helps distinguish a cardiac cause from a pulmonary one.
Management at the bedside
Three measures are used in parallel:
- Upright positioning and oxygen therapy to improve respiratory mechanics and oxygen saturation as soon as the patient arrives
- Intravenous diuretics (furosemide) to reduce fluid overload and lower pulmonary capillary pressure
- Vasodilators (nitrates) if blood pressure allows, to reduce left ventricular preload and afterload
Non-invasive ventilation (NIV) is a first-line option in severe cases. It reduces the work of breathing and improves gas exchange without the need for intubation.
Non-cardiogenic pulmonary edema: when the alveolar-capillary barrier breaks down
Non-cardiogenic pulmonary edema follows a different mechanism. Capillary pressure may be entirely normal. The problem lies in the alveolar-capillary membrane, whose permeability increases in response to direct injury (pneumonia, inhalation of smoke or gastric contents) or indirect injury (sepsis, pancreatitis, multiple trauma).
The fluid filling the alveoli is an exudate rich in proteins, fibrin, and inflammatory cells. The functional outcome is the same (acute respiratory distress), but diuretics are ineffective and may even be harmful because there is no fluid overload to correct.
Link to ARDS and new definitions
Severe non-cardiogenic pulmonary edema corresponds to acute respiratory distress syndrome (ARDS). The 2024 global definition (Matthay et al.) broadened the diagnostic criteria: ARDS can now be identified in patients receiving high-flow oxygen therapy or non-invasive ventilation, and lung ultrasound is recognized as a diagnostic imaging tool. This change makes early detection easier, including outside the intensive care unit.
The challenge remains the gray area: heart failure and lung injury can coexist in the same patient. Sepsis can decompensate pre-existing heart disease, resulting in mixed pulmonary edema. Echocardiography and the clinical context remain the best tools for disentangling the mechanisms involved.
Volume-overload pulmonary edema: a mechanism often caused by medical treatment
This third type is sometimes overlooked in classifications because it shares features with cardiogenic pulmonary edema. The mechanism involves excess circulating volume that exceeds the heart’s ability to adapt, even when the heart is functioning normally.
It typically occurs after excessive fluid resuscitation (large-volume infusions around the time of surgery), in cases of kidney failure with fluid and sodium retention, or after rapid blood transfusions. The heart is not diseased, but is overwhelmed by a volume it cannot handle.
Diagnosis is based on the clinical context: an imbalanced fluid intake and output record, rapid weight gain, and a history of kidney disease. Echocardiography often shows preserved ventricular function, ruling out primary cardiac failure. Treatment involves fluid restriction, diuretics, and sometimes renal replacement therapy in severe cases with associated kidney failure.
In practice, the distinction between volume overload and cardiac decompensation can depend on the patient’s baseline condition. An older heart with reduced compliance may not tolerate fluid resuscitation that a younger heart could handle. A full hemodynamic assessment, using ultrasound if needed, remains key to tailoring treatment to the underlying mechanism.
